Use of GLP1 medications, together with research into new therapeutic applications, is fueling a multimillion-dollar market built around this breakthrough.
Trust us to provide the highest standard of care and support throughout your treatment
CNS(Central Nervous System, ) ,
Yes, there can be differences in the dosing schedules (sometimes called titration) and injection volumes between the two medications
While weight loss may improve focus, Mounjaro is not designed for ADHD treatment and requires clinical guidance tailored to ADHD management
[2] Heres what we know about side effects from the STEP UP clinical trial so far: Around 1 in 3 patients taking Wegovy 7.2 mg experienced nausea Around 1 in 6 patients experienced diarrhoea Around 1 in 6 patients experienced vomiting Around 1 in 7 patients experienced constipation A side effect called 'dysaesthesia' was also noted in the STEP UP trial, occurring in nearly 1 in 4 of participants taking Wegovy 7.2 mg